Edesa Biotech’s Founder Makes Strategic Investment in the Company
31. Oktober 2024 08:15 ET
|
Edesa Biotech, Inc.
TORONTO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...
Edesa Biotech Announces Upcoming Conference Schedule
21. Oktober 2024 08:15 ET
|
Edesa Biotech, Inc.
Edesa Biotech Announces Upcoming Conference Schedule
Edesa Biotech Reports Fiscal 3rd Quarter 2024 Results
09. August 2024 16:20 ET
|
Edesa Biotech, Inc.
TORONTO, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory...